Cellular Interactions and Competition in Clonal Hematopoiesis

NIH RePORTER · NIH · F30 · $49,821 · view on reporter.nih.gov ↗

Abstract

PROJECT SUMMARY Clonal hematopoiesis (CH) is the expansion of peripheral blood cells derived from a single mutant hematopoietic stem cell (HSC) in the absence of hematological malignancy. CH is associated with increased risk of several age associated diseases however the disease manifestation and prognosis varies based on which gene is mutated, the variant, and the mutational burden. Most individuals over the age of 55 have at least one detectable clone, and of those, 25% have two or more mutant populations present. Despite this vast and variable health burden, little is known about how interactions between mutant clones influences clonal expansion. The top three genes mutated in CH are epigenetic modifiers DNA Methyltransferase 3A (Dnmt3a), Ten- Eleven Translocation Protein 2 (Tet2) and Additional Sex Comb like 1 (Asxl1). Several independent studies of each mutant clone in isolation have identified that these mutations provide HSCs with a survival advantage over wild type HSCs in the setting of inflammatory stressors, like infections. Additionally, these mutant clones not only respond to inflammatory stimuli, but are also potent produces of pro-inflammatory cytokines that aids in creating an environment that selects for the survival of the mutant clone. Transcriptionally, CH clones have a mutation- specific resistance to extinction by either attenuating the inflammatory stress response or preventing terminal differentiation. Collectively, these studies suggest Dnmt3a, Asxl1 and Tet2 deficient clones have a mutation- specific resistance to inflammatory pressures, and they perpetuate this selective advantage by inducing pro- inflammatory states. These studies also suggest that mutant clones and their progeny may impact the expansion of neighboring clones, but such clonal interactions and competition has not been studied. Preliminary experiments show Tet2 mutant clonal expansion is impaired when in the presence of Asxl1 and Dnmt3a-mutant cells. Interestingly, Asxl1 mutant clonal expansion is unaffected by other mutant clones and remains consistent with the presence or absence of other mutant clones. This unexpected finding suggests unexplored interactions between clones having a mutation-specific effect on clonal expansion. Based on published and preliminary data, I hypothesize that mutations influence the inflammatory microenvironment as well as the transcriptional response to stimuli such that clones behave differently in the presence or absence of other clones. In Aim 1, I will characterize clonal competition by measuring clonal expansion of Dnmt3a, Asxl1 and Tet2 deficient clones when in the presence and absence of other mutant clones following inflammatory challenge. In Aim 2, I will utilize single cell RNA sequence and ex vivo culturing experiments to identify interactions underlying clonal expansion between Dnmt3a, Asxl1 and Tet2 deficient HSCs and downstream immune cells. With the successful completion of these aims, I will be able to char...

Key facts

NIH application ID
10998269
Project number
1F30HL172468-01A1
Recipient
BAYLOR COLLEGE OF MEDICINE
Principal Investigator
Apoorva Thatavarty
Activity code
F30
Funding institute
NIH
Fiscal year
2024
Award amount
$49,821
Award type
1
Project period
2024-12-01 → 2026-11-30